SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1912)2/21/1999 7:22:00 PM
From: Walter Morton  Respond to of 2742
 
They make about $12 Million in sales per year, they are profitable, and they only have about 9 million shares outstanding. Their stock price is only $1.375.

If HMGN can only get $1.375 for their stock, why should we think CIST is worth more than $.25? CIST sales are about $500,000 per year, not profitable, and has 22 million shares outstanding.

By the way, HMGN is the company that I said CIST should buy when HMGN was below or around $.80.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News